Can J Cardiol. 2010 Nov; 26 (9): 489–496.
44. Kuipers RS, Luxwolda MF, Dijck-Brouwer DA, et al. Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet. Br J Nutr. 2010 Dec; 104 (11): 1666–1687.
45. Там же.
46. DeFilippis AP, Sperling LS. Understanding omega-3’s. Am Heart J. 2006 Mar; 151 (3): 564–570.
47. Kuipers RS, Luxwolda MF, Dijck-Brouwer DA, et al. Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet. Br J Nutr. 2010 Dec; 104 (11): 1666–1687.
48. Hite AH, Feinman RD, Guzman GE, et al. In the face of contradictory evidence: report of the Dietary Guidelines for Americans Committee. Nutrition. 2010 Oct; 26 (1): 915–924.
49. Wells, HF, Buzby JC. Dietary assessment of major trends in U.S. food consumption, 1970–2005. ERS Report Summary. 2008 Mar.. 50. Food labeling: trans fatty acids in nutrition labeling, nutrient content claims, and health claims. Final rule. Fed Regist. 2003 Jul 11; 68 (133): 41433–1506.
1. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 2008 Jun; 233 (6): 674–688.
2. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002 Oct; 56 (8): 365–379.
3. Там же.
4. Leaf A, Weber PC. A new era for science in nutrition. Am J Clin Nutr.1987 May; 45 (5 Suppl): 1048–1053.
5. Там же.
6. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002 Oct; 56 (8): 365–379.
7. Leaf A, Weber PC. A new era for science in nutrition. Am J Clin Nutr. 1987 May; 45 (5 Suppl): 1048–1053.
8. Sperling LS, Nelson JR. History and future of omega-3 fatty acids in cardiovascular disease. Curr Med Res Opin. 2016; 32 (2): 301–311.
9. Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand 1980 Jan-Dec; 208: 401–406.
10. Okuyama H, Kobayashi T, Watanabe S. Dietary fatty acids-the N-6/N-3 balance and chronic elderly diseases. Excess linoleic acid and relative N-3 deficiency syndrome seen in Japan. Prog Lipid Res.1996 Dec; 35 (4): 409–457.
11. Там же.
12. Там же.
13. Там же.
14. Imaida K, Sato H, Okamiya H, et al. Enhancing effect of high fat diet on 4-nitroquinoline 1-oxide-induced pulmonary tumorigenesis in ICR male mice. Jpn J Cancer Res.1989 Jun; 80 (6): 499–502.
15. Okuyama H, Kobayashi T, Watanabe S. Dietary fatty acids-the N-6/N-3 balance and chronic elderly diseases. Excess linoleic acid and relative N-3 deficiency syndrome seen in Japan. Prog Lipid Res. 1996 Dec; 35 (4): 409–457.
16. Там же.
17. Там же.
18. Там же.
19. Malhotra SL. Epidemiology of ischaemic heart disease in India with special reference to causation. Br Heart J.1967 Nov; 29 (6): 895–905.
20. Там же.
21. Padmavati S. Epidemiology of cardiovascular disease in India. II. Ischemic heart disease. Circulation. 1962 Apr; 25: 711–717.
22. Malhotra SL. Epidemiology of ischaemic heart disease in India with special reference to causation. Br Heart J. 1967 Nov; 29 (6): 895–905.
23. Там же.
24. Там же.
25. Там же.
26. Там же.
27. Ghee [Интернет]. Wikipedia. 2018 May 21 [открыто 4 июня 2018]. Доступно по адресу https://en.wikipedia.org/wiki/Ghee.
28. Padmavati S. Epidemiology of cardiovascular disease in India. II. Ischemic heart disease. Circulation.1962 Apr; 25: 711–717.
29. Malhotra SL. Geographical aspects of acute myocardial infarction in India with special reference to patterns of diet and eating. Br Heart J. 1967 May; 29 (3): 337–344.
30. Padmavati S. Epidemiology of cardiovascular disease in India. II. Ischemic heart disease. Circulation. 1962 Apr; 25: 711–717.
31. Там же.
32. Там же.
33. Raheja BS, Sadikot SM, Phatak RB, et al. Significance of the N-6/N-3 ratio for insulin action in diabetes. Ann N Y Acad Sci.1993 Jun 14; 683: 258–271.
34. Там же.
35. Там же.
36. Lindeberg S, Nilsson-Ehle P, Vessby B. Lipoprotein composition and serum cholesterol ester fatty acids in nonwesternized Melanesians. Lipids. 1996 Feb; 31 (2): 153–158.
37. Там же.
38. Esposito K, Marfella R, Ciotola M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004 Sep 22; 292 (12): 1440–1446.
39. Там же.
40. Singh RB, Demeester F, Wilczynska A. The tsim tsoum approaches for prevention of cardiovascular disease. Cardiol Res Pract. 2010; 2010: 824938.
41. Adapted from Singh RB, Demeester F, Wilczynska A. The tsim tsoum approaches for prevention of cardiovascular disease. Cardiol Res Pract. 2010; 2010: 824938.
42. Massaro M, Habib A, Lubrano L, et al. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci U S A.2006 Oct 10; 103 (41): 15184–15189.
43. Sun Q, Ma J, Campos H, et al. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr.2007 Jul; 86 (1): 74–81.
44. Grenon SM, Conte MS, Nosova E, et al. Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease. J Vasc Surg. 2013 Nov; 58 (5): 1283–90.
45. Harris WS. The omega-3 index as a risk factor for coronary heart disease. Am J Clin Nutr. 2008 Jun; 87 (6): 1997s–2002s.
46. Farzaneh-Far R, Harris WS, Garg S, et al. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis. 2009 Aug; 205 (2): 538–543.
1. Pope AJ, Druhan L, Guzman JE, et al. Role of DDAH-1 in lipid peroxidation product-mediated inhibition of endothelial NO generation. Am J Physiol Cell Physiol.2007 Nov;293(5): C167-86.
2. Там же.
3. Chen L, Zhou JP, Kuang DB, et al. 4-HNE increases intracellular ADMA levels in cultured HUVECs: evidence for miR-21-dependent mechanisms. PLoS One. 2013 May 22; 8 (5): e64148.
4. Yla-Herttuala S, Palinski W, Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989 Oct; 84 (4): 1086–1095.
5. Lahoz C, Alonso R, Ordovas JM, et al. Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. Eur J Clin Invest. 1997 Sep; 27 (9): 780–787.
6. Gradinaru D, Borsa C, Ionescu C, et al. Oxidized LDL and NO synthesis – Biomarkers of endothelial dysfunction and ageing. Mech Ageing Dev. 2015 Nov; 151: 101–113.
7. Bonaa KH, Bjerve KS, Straume B, et al. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromso study. N Engl J Med. 1990; 322: 795–801.
8. Там же.
9. Ferrara LA, Raimondi AS, d’Episcopo L, et al. Olive oil and reduced need for antihypertensive medications. Arch Intern Med. 2000 Mar 27; 160 (6): 837–842.
10. Там же.
11. Там же.
12. Pope AJ, Druhan L, Guzman JE, et al. Role of DDAH-1 in lipid peroxidation product-mediated inhibition of endothelial NO generation. Am J Physiol Cell Physiol. 2007 Nov; 293 (5): C1679–1686.
13. Wang XL, Zhang L, Youker K, et al. Free fatty acids inhibit insulin signalingstimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes. 2006 Aug; 55 (8): 2301–2310.
14. Gradinaru D, Borsa C, Ionescu C, et al. Oxidized LDL and NO synthesis – Biomarkers of endothelial dysfunction and ageing. Mech Ageing Dev. 2015 Nov; 151: 101–113.
15. Lahoz C, Alonso R, Ordovas JM, et al. Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. Eur J Clin Invest. 1997 Sep; 27 (9): 780–787.
16. Marchix J, Choque B, Kouba M, et al. Excessive dietary linoleic acid induces proinflammatory markers in rats. J Nutr Biochem2015 Dec;26(12):1434-41.
17. Hennig B, Toborek M, McClain CJ. High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. J Am Coll Nutr. 2001 Apr; 20 (2 Suppl): 97–105.
18. Simpson HC, Mann JI, Meade TW, et al. Hypertriglyceridaemia and hypercoagulability. Lancet 1983 Apr 9; 1 (8328): 786–790.
19. Yosefy C, Viskoper JR, Laszt A, et al. The effect of fish oil on hypertension, plasma lipids and hemostasis in hypertensive, obese, dyslipidemic patients with and without diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids. 1999 Aug; 61 (2): 83–87.
20. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A metaanalysis of controlled trials. Circulation. 1993 Aug 1; 88 (2): 523–533.
21. Appel LJ, Miller ER 3rd, Seidler AJ, et al. Does supplementation of diet with ‘fish oil’ reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med. 1993 Jun 28; 153 (12): 1429–1438.
22. Geleijnse JM, Giltay EJ, Grobbee DE, et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002 Aug; 20 (8): 1493–1499.